24.04
-0.82 (-3.30%)
| Penutupan Terdahulu | 24.86 |
| Buka | 24.99 |
| Jumlah Dagangan | 433,209 |
| Purata Dagangan (3B) | 358,711 |
| Modal Pasaran | 1,157,479,168 |
| Harga / Pendapatan (P/E Ke hadapan) | 454.55 |
| Harga / Jualan (P/S) | 10.52 |
| Harga / Buku (P/B) | 3.03 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 Nov 2025 |
| Margin Keuntungan | -11.86% |
| Margin Operasi (TTM) | -5.09% |
| EPS Cair (TTM) | -0.190 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 29.90% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 7.64% |
| Nisbah Semasa (MRQ) | 4.73 |
| Aliran Tunai Operasi (OCF TTM) | 14.63 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 39.10 M |
| Pulangan Atas Aset (ROA TTM) | -0.79% |
| Pulangan Atas Ekuiti (ROE TTM) | -2.52% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Bercampur | Menurun |
| Medical Instruments & Supplies (Global) | Bercampur | Menurun | |
| Stok | BioLife Solutions, Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 2.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -1.0 |
| Purata | 0.50 |
|
BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing, and marketing a portfolio of biopreservation tools and services for cells, tissues, and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 2.84% |
| % Dimiliki oleh Institusi | 100.53% |
| Julat 52 Minggu | ||
| Median | 32.00 (33.11%) | |
| Jumlah | 1 Beli | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 29 Dec 2025 | 32.00 (33.11%) | Beli | 25.12 |
| 24 Nov 2025 | 32.00 (33.11%) | Beli | 26.35 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 12 Jan 2026 | Pengumuman | BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2025 Unaudited Revenue from Continuing Operations |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |